James Rolke

CIK 1693858 · Chief Executive Officer · last filed 2026-05-01

James Rolke is a Chief Executive Officer who has filed 50 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider had shares withheld for taxes covering $11.4K of REVBW on May 1, 2026. Across all open-market trades the lifetime net is +$31.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.0K

Companies

2

Total Filings

50

Lifetime Open-Market Net

$31.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
REVBW Chief Executive Officer 214,738 $0.01 $2.0K $0 6 2026-05-01
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Chief Scientific Officer 81,771 $6.22 $508.6K $31.7K 44 2020-06-02

Recent Filings

50 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-01 REVBW Tax (F) −10,115 -$11.4K EDGAR
2026-02-05 REVBW Tax (F) −8,521 -$15.8K EDGAR
2026-01-12 REVBW Grant (A) +532,829 $479.5K EDGAR
2025-10-31 REVBW Grant (A) +390,614 $500.0K EDGAR
2025-02-13 REVBW Grant (A) +30,095 $116.5K EDGAR
2023-02-28 REVBW Grant (A) $0 EDGAR
2020-06-02 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +205 $822 EDGAR
2020-05-19 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +140 $820 EDGAR
2020-05-04 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +133 $821 EDGAR
2020-04-17 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Grant (A) +146 $819 EDGAR
Showing 110 of 50
Page 1 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.